Spire Wealth Management - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 40 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$11,000
-26.7%
1,8000.0%0.00%
Q1 2021$15,0001,8000.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 793,170$7,686,0000.94%
Sio Capital Management, LLC 189,062$1,832,0000.36%
J. Goldman & Co LP 168,749$1,635,0000.11%
Rubric Capital Management LP 57,518$557,0000.05%
GSA CAPITAL PARTNERS LLP 13,823$134,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 66,899$648,0000.02%
PDT Partners, LLC 11,539$112,0000.01%
Global Financial Private Client, LLC 266$2,4840.00%
Hartford Financial Management Inc. 598$6,0000.00%
FIRST TRUST ADVISORS LP 34,353$333,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders